Key points from article :
An artificial intelligence tool by Oxipit that reads chest X-rays without a radiologist got regulatory clearance in the European Union.
The tool, ChestLink, scans chest X-rays and automatically sends patient reports.
Images that the tool flags as having a potential problem are sent to a radiologist for review.
Automating the process for those scans could cut down on radiologists’ workloads.
The tech now has a CE mark certification in the EU, which signals that a device meets safety standards.
Oxipit spokesperson told that the company plans to file with the FDA as well.
Professional organizations have spoken out against the idea...saying that autonomous AI wasn’t ready for clinical use.
Oxipit said that ChestLink made zero “clinically relevant” errors during pilot programs at multiple locations.
In a new setting, the tool should be used under supervision for some period before it starts working autonomously.
Expects the first healthcare organizations to be using the autonomous tool by 2023.
